Ultragenyx Pharmaceutical (RARE) Market Capitalization (2014 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded Market Capitalization of $3.29 billion in Q2 2026, down 6.0% from $3.5 billion a year earlier but up 59.9% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Market Capitalization (2014 - 2026) Analysis & Trends
For FY2025, Ultragenyx Pharmaceutical reported Market Capitalization of $2.22 billion, down 42.9% from FY2024.
- Annual Market Capitalization has a five-year compound annual growth rate of -24.8% (FY2020 to FY2025).
- Across earlier years, Market Capitalization came in at $3.89 billion in FY2024 (-1.2%), $3.94 billion in FY2023 (+21.0%), $3.25 billion in FY2022 (-44.2%) and $5.83 billion in FY2021 (-37.0%).
- Quarterly Market Capitalization has ranged from $2.06 billion in Q1 2026 to $6.13 billion in Q3 2021 over the past five years.
- On a year-over-year basis, Market Capitalization has declined for seven consecutive quarters, with an average decline of 6.7% over the last eight quarters.
- Peak year-over-year performance for Market Capitalization in the last five years was growth of 99.3% in Q3 2024, against a decline of 52.7% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.06 billion (Q1 2026), $2.22 billion (Q4 2025) and $2.9 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.29 Bn |
| Mar 31, 2026 | 2.06 Bn |
| Dec 31, 2025 | 2.22 Bn |
| Sep 30, 2025 | 2.90 Bn |
| Jun 30, 2025 | 3.50 Bn |
| Mar 31, 2025 | 3.40 Bn |
| Dec 31, 2024 | 3.89 Bn |
| Sep 30, 2024 | 5.13 Bn |
| Jun 30, 2024 | 3.79 Bn |
| Mar 31, 2024 | 3.88 Bn |
| Dec 31, 2023 | 3.94 Bn |
| Sep 30, 2023 | 2.57 Bn |
| Jun 30, 2023 | 3.30 Bn |
| Mar 31, 2023 | 2.83 Bn |
| Dec 31, 2022 | 3.25 Bn |
| Sep 30, 2022 | 2.90 Bn |
| Jun 30, 2022 | 4.18 Bn |
| Mar 31, 2022 | 5.07 Bn |
| Dec 31, 2021 | 5.83 Bn |
| Sep 30, 2021 | 6.13 Bn |
API Access
Ultragenyx Pharmaceutical Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();